The UCSD Gene Therapy Initiative + CLS/CIRM Cell & Gene Therapy Symposium will take place September 16–17, 2026, in La Jolla, California. The two-day event brings together the UC San Diego Gene Therapy Initiative, California Life Sciences (CLS), and the California Institute for Regenerative Medicine (CIRM) to explore the future of cell and gene therapy.
The program features perspectives from academic and industry leaders across the cell and gene therapy ecosystem, with discussions spanning cell-based safety models, ex vivo and in vivo genetic therapies, gene editing, manufacturing, commercialization, regulatory considerations, and patient access.
UCSD Gene Therapy Initiative + CLS/CIRM Cell & Gene Therapy Symposium
📅 September 16–17, 2026
📍 Salk Institute for Biological Studies | La Jolla, CA
Connect with Eurofins Clinical Trial Solutions during the symposium to discuss your upcoming cell and gene therapy programs and bioanalytical testing needs.
Our scientific teams provide specialized expertise across:
By combining scientific expertise, regulatory experience, and fit-for-purpose analytical strategies, Eurofins Clinical Trial Solutions supports sponsors navigating the complex analytical needs of cell and gene therapy development.
Our Team Attending
Connect with our team onsite throughout the conference:
Attending the UCSD Gene Therapy Initiative + CLS/CIRM Cell & Gene Therapy Symposium? Schedule time with our experts to discuss your upcoming cell and gene therapy programs, bioanalytical challenges, and testing needs.